is janumet a glp 1 XR: Dosage & Side Effects Janumet Dosage: Strengths, Timing, and

With the rise of GLP-1 drugs like Ozempic, Wegovy, and Mounjaro, conversations surrounding their inclusion in employee benefits programs are expanding in new directions.

With Semaglutide patents expiring in 2026, Indian pharma has a chance to lead the GLP-1 drug market.

patients had CKD stages 1 to 5 diagnosed by Kidney Disease: Improving Global Outcomes guidelines plus at least 3 months of one of the following: moderate to severe albuminuria regardless of estimated glomerular filtration rate (eGFR), eGFR less than 90 mL/min/1.73 m2 with structural abnormalities of the kidney or urinary sediment abnormalities, or eGFR less than 60 mL/min/1.73 m2

In a consumer study of 274 people taking GLP-1 Probiotic for 6 weeks, 91% reported reduced food cravings

Undeniably, this is an exciting time for the obesity market as it is facing a major inflection point

Amylyx updates investors on its rare disease pipeline, including avexitides Phase 3 LUCIDITY trial, AMX0035 in Wolfram syndrome, AMX0114 in ALS, and a $317M cash position with runway into 2028 through potential avexitide approval and launch in 2027.